Evidence map›Paper›PMID 26199424›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2015

Making Transporter Models for Drug-Drug Interaction Prediction Mobile.

Sean Ekins, Alex M Clark, Stephen H Wright

Abstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular and cellular physiology of organic cation transporter 2.American journal of physiology. Renal physiology · 2019
    Review
  6. Article
  7. Data Mining and Computational Modeling of High-Throughput Screening Datasets.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  8. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.European journal of drug metabolism and pharmacokinetics · 2017
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sean EkinsCollaborations Pharmaceuticals, Inc., and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.); Collaborative Drug Discovery, Burlingame, California (S.E.); Molecular Materials Informatics, Inc., Montreal, Quebec, Canada (A.M.C.); and Department of Physiology, University of Arizona, Tucson, Arizona (S.H.W.) ekinssean@yahoo.com.
Alex M ClarkCollaborations Pharmaceuticals, Inc., and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.); Collaborative Drug Discovery, Burlingame, California (S.E.); Molecular Materials Informatics, Inc., Montreal, Quebec, Canada (A.M.C.); and Department of Physiology, University of Arizona, Tucson, Arizona (S.H.W.).
Stephen H WrightCollaborations Pharmaceuticals, Inc., and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.); Collaborative Drug Discovery, Burlingame, California (S.E.); Molecular Materials Informatics, Inc., Montreal, Quebec, Canada (A.M.C.); and Department of Physiology, University of Arizona, Tucson, Arizona (S.H.W.).

Funding

Moleculer Organization of Renal Organic Cation TransportR01DK058251 · NIDDK · UNIVERSITY OF ARIZONA · PI CHANG, GEOFFREY A, WRIGHT, STEPHEN H · 2000 to 2016
$5.6M
Biocomputation across distributed private datasets to enhance drug discoveryR44TR000942 · NCATS · COLLABORATIVE DRUG DISCOVERY, INC. · PI BUNIN, BARRY A · 2013 to 2018
$2.9M
Molecular Organization of the Organic Cation-Proton Exchanger, MATE1R01DK080801 · NIDDK · UNIVERSITY OF ARIZONA · PI CHANG, GEOFFREY A, WRIGHT, STEPHEN H · 2010 to 2014
$2.5M
NCATS NIH HHS 9R44TR000942-02NCATS NIH HHS R44 TR000942NIDDK NIH HHS 1R01DK080801-5NIDDK NIH HHS 5R01DK058251-14NIDDK NIH HHS R01 DK058251NIDDK NIH HHS R01 DK080801
6 · The paper itself

Abstract

The past decade has seen increased numbers of studies publishing ligand-based computational models for drug transporters. Although they generally use small experimental data sets, these models can provide insights into structure-activity relationships for the transporter. In addition, such models have helped to identify new compounds as substrates or inhibitors of transporters of interest. We recently proposed that many transporters are promiscuous and may require profiling of new chemical entities against multiple substrates for a specific transporter. Furthermore, it should be noted that virtually all of the published ligand-based transporter models are only accessible to those involved in creating them and, consequently, are rarely shared effectively. One way to surmount this is to make models shareable or more accessible. The development of mobile apps that can access such models is highlighted here. These apps can be used to predict ligand interactions with transporters using Bayesian algorithms. We used recently published transporter data sets (MATE1, MATE2K, OCT2, OCTN2, ASBT, and NTCP) to build preliminary models in a commercial tool and in open software that can deliver the model in a mobile app. In addition, several transporter data sets extracted from the ChEMBL database were used to illustrate how such public data and models can be shared. Predicting drug-drug interactions for various transporters using computational models is potentially within reach of anyone with an iPhone or iPad. Such tools could help prioritize which substrates should be used for in vivo drug-drug interaction testing and enable open sharing of models.

Indexed as

Models, BiologicalBayes TheoremBiological TransportDrug InteractionsForecastingMembrane Transport ProteinsMobile ApplicationsPharmaceutical PreparationsMembrane Transport ProteinsPharmaceutical Preparations

Identifiers

PMID26199424
PMCPMC4576675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.